Publication | Closed Access

Pristinamycin as adjunctive therapy in the management of Gram-positive multi-drug resistant organism (MDRO) osteoarticular infection

Adjunctive TherapyAntimicrobial SusceptibilityHealth SciencesOrthopaedic SurgeryAntibioticsMedicineOsteoarthritisPharmacotherapyProsthetic Joint InfectionsAntimicrobial ChemotherapyAntimicrobial CompoundPharmacologyClinical MicrobiologyAntimicrobial ResistanceOsteoarticular InfectionDrug Resistance